enVVeno Medical Corporation (NVNO) Operating cash flow 2017–2025
enVVeno Medical Corporation (NVNO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.6MFY2025 · since FY2017: -$4.2M → -$15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.6M | +7.5% |
| FY2024 | -$16.8M | +10.7% |
| FY2023 | -$18.9M | -20.7% |
| FY2022 | -$15.6M | -31.8% |
| FY2021 | -$11.8M | -54.3% |
| FY2020 | -$7.7M | -30.2% |
| FY2019 | -$5.9M | +7.2% |
| FY2018 | -$6.4M | -51.2% |
| FY2017 | -$4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVNO financial trends
NVNO RevenueNVNO Net incomeNVNO Net marginNVNO Gross profitNVNO Gross marginNVNO Operating incomeNVNO Operating marginNVNO Free cash flowNVNO Capital expendituresNVNO Return on equityNVNO Stock buybacksNVNO Dividends paidNVNO Total assetsNVNO Total liabilitiesNVNO Shareholders’ equityNVNO overview →